GENEVA, March 16 -- NANJING QINLING PHARMACEUTICAL TECHNOLOGY COMPANY LIMITED (Building B, Phase I, Zhongdan Ecological Life Science Industrial Park, No. 3-1 Xinjinhu Road, Jiangbei New AreaNanjing, Jiangsu 210000), 南京芩领医药科技有限公司 (中国江苏省南京市江北新区新锦湖路3-1号中丹生态生命科学产业园一期B栋) filed a patent application (PCT/CN2023/120536) for "USE OF ORAL-NASAL INHALATION TYPE WOGONIN FORMULATION IN THE PREPARATION OF DRUGS TREATING BRAIN GLIOMA" on Sep 22, 2023. With pub...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.